Connection

Marco Massari to Cost-Benefit Analysis

This is a "connection" page, showing publications Marco Massari has written about Cost-Benefit Analysis.
Connection Strength

0.021
  1. Modeling cost-effectiveness and health gains of a "universal" versus "prioritized" hepatitis C virus treatment policy in a real-life cohort. Hepatology. 2017 12; 66(6):1814-1825.
    View in: PubMed
    Score: 0.021
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.